Are Maximus Interna. latest results good or bad?

Nov 09 2025 07:15 PM IST
share
Share Via
Maximus International's latest Q2 FY26 results show strong sales growth of 27.90% year-on-year, but declining operating profit margins and negative cash flows raise concerns about its operational sustainability. While revenue is at an all-time high, the reliance on non-operating income and cash flow challenges suggest potential risks ahead.
Maximus International's latest financial results for Q2 FY26 show a complex picture of growth amid operational challenges. The company reported consolidated net sales of ₹45.84 crores, reflecting a year-on-year growth of 27.90% and marking the highest quarterly revenue in its history. This growth continues a five-year sales trajectory, indicating sustained demand in the trading and distribution sector.
However, the underlying operational metrics present concerns. The consolidated net profit reached ₹2.77 crores, which is a 30.05% increase year-on-year, yet the operating profit margin (excluding other income) contracted to 7.81%, down from 9.71% in the previous year. This decline in margins suggests potential issues related to competitive pressures or cost management inefficiencies. Additionally, the company's reliance on other income, which constituted a significant portion of profit before tax, raises questions about the sustainability of its earnings. The financial data also indicates that while the company has achieved impressive revenue growth, it faces critical challenges in cash flow generation, with negative operating cash flows reported in the previous fiscal year. This situation highlights a potential risk to the company's operational viability and raises concerns about its ability to maintain growth without adequate cash generation. Overall, while Maximus International has demonstrated strong sales growth, the deterioration in operating margins, reliance on non-operating income, and negative cash flows suggest that the company is navigating significant operational hurdles. Furthermore, there has been an adjustment in its evaluation, reflecting the market's cautious outlook on its financial health and sustainability. Investors should monitor these trends closely as they assess the company's future performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Maximus International Ltd Falls to 52-Week Low of Rs.9.65
Jan 29 2026 10:06 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 28 2026 10:10 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.7
Jan 28 2026 10:00 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.71
Jan 27 2026 11:20 AM IST
share
Share Via
Why is Maximus International Ltd falling/rising?
Jan 14 2026 12:50 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 05 2026 10:13 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
50 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
50 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
50 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
50 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
50 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
50 minutes ago
share
Share Via